US PTO has granted BioKier patent 9,301,938 which was issued on April 5, 2016. The present invention relates to a method of treating obesity, diabetes and other metabolic diseases by fixed combination of BioKier’s product with monoamine reuptake inhibitors like Bupropion.
US PTO has granted BioKier patent 9,314,444 which was issued on April 19, 2016. The present invention relates to a method of treating NASH or NAFLD by BioKier’s products.